Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhejiang Jiuzhou Pharmaceutical Co., Ltd
  6. Summary
    603456   CNE100001W36

ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD

(603456)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-12-01
38.90 CNY   -3.28%
10/25Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
10/11Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on September 1, 2022.
CI
09/28Jiuzhou Pharma to Purchase Factory From Sandoz China for $26 Million
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
11/28/2022 11/29/2022 11/30/2022 12/01/2022 12/02/2022 Date
40.3 40.29 39.6 40.22 38.9 Last
3587116 4881274 4152598 4401327 5852453 Volume
-2.28% -0.02% -1.71% +1.57% -3.28% Change
Estimated financial data (e)
Sales 2022 5 770 M 822 M 822 M
Net income 2022 930 M 133 M 133 M
Net Debt 2022 - - -
P/E ratio 2022 35,0x
Yield 2022 0,77%
Sales 2023 7 302 M 1 040 M 1 040 M
Net income 2023 1 237 M 176 M 176 M
Net Debt 2023 - - -
P/E ratio 2023 26,2x
Yield 2023 1,00%
Capitalization 32 453 M 4 623 M 4 623 M
Capi. / Sales 2022 5,62x
Capi. / Sales 2023 4,44x
Nbr of Employees 4 083
Free-Float 53,5%
More Financials
Company
Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the research, development, production and sales of chemical Active Pharmaceutical Ingredients (API) and intermediates. The Company mainly operates through two segments, including the New Drug and Intermediates Contract Development and Manufacturing Organization (CDMO) segment and the Specialty APIs and Intermediates segment. The... 
Sector
Pharmaceuticals
Calendar
04/26Earnings Release
More about the company
Ratings of Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
10/25Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months E..
CI
10/11Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announ..
CI
09/28Jiuzhou Pharma to Purchase Factory From Sandoz China for $26 Million
MT
09/01Zhejiang Jiuzhou Pharmaceutical Co., Ltd announces an Equity Buyback for CNY 100 millio..
CI
08/31Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 30 m..
CI
08/31Zhejiang Jiuzhou Pharmaceutical Co., Ltd authorizes a Buyback Plan.
CI
08/04Zhejiang Jiuzhou Pharmaceutical Co., Ltd announced that it expects to receive CNY 2.5 b..
CI
07/21Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year End..
CI
04/19Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter..
CI
03/21Chinese Shares Extend Gains; Four Drugmakers Rally on Pfizer Deal
MT
03/20Fosun Pharma, Huahai, Three Other Chinese Firms to Produce Ingredients For Pfizer&rsquo..
MT
01/04Zhejiang Jiuzhou Pharmaceutical Co., Ltd signed Investment Agreement to acquire a 25.8%..
CI
2021Nan Jing Kang Chuan Ji Pharmatech Co., Ltd. announced that it expects to receive CNY 80..
CI
2021Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it has received CNY 30..
CI
2021Zhejiang Jiuzhou Pharmaceutical Co., Ltd completed the acquisition of Teva Pharmaceutic..
CI
More news
News in other languages on ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
10/25Zhejiang Jiuzhou Pharmaceutical Co., Ltd. annonce ses résultats pour les neuf mois term..
09/28Jiuzhou Pharma va racheter l'usine de Sandoz China pour 26 millions de dollars
09/01Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:6034..
08/31Zhejiang Jiuzhou Pharmaceutical Co., Ltd autorise un plan de rachat.
07/21Zhejiang Jiuzhou Pharmaceutical Co., Ltd annonce ses résultats pour le semestre clos le..
More news
ETFs positioned on ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
VanEck New China ESG - USD1.06%8.64%-NC
KraneShares MSCI All China Health Care Inde...0.69%7.97%China
KraneShares Emerging Market Healthcare Inde...0.67%3.96%NC
China Southern SSE 380 Index ETF - CNY0.6%1.09%-China
Xtrackers Harvest CSI 500 China-A Shares Sm...0.34%5.30%China
More ETFs positioned on ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Chart ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Duration : Period :
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 38,90 CNY
Average target price 50,46 CNY
Spread / Average Target 29,7%
EPS Revisions
Managers and Directors
Zhi Hong Chen General Manager & Director
Yu Jie Sha Chief Financial Officer
Li Rong Hua Chairman
Meng Sheng Sun Chairman-Supervisory Board
Yuan Qiang Li Director-Technology, Research & Development
Sector and Competitors